Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Profound Medical (PROF) Short-term Investments (2021 - 2022)

Profound Medical has reported Short-term Investments over the past 2 years, most recently at $13000.0 for Q3 2022.

For Q3 2022, Short-term Investments changed N/A year-over-year to $13000.0; the TTM value through Sep 2022 reached $13000.0, changed N/A, while the annual FY2021 figure was $161000.0, N/A changed from the prior year.
Short-term Investments for Q3 2022 was $13000.0 at Profound Medical, down from $161000.0 in the prior quarter.
Over five years, Short-term Investments peaked at $161000.0 in Q4 2021 and troughed at $13000.0 in Q3 2022.